| [1] |
Siegel RL, Wagle NS, Cercek A, et al. Colorectal cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73(3): 233-254.
|
| [2] |
Mauri G, Monfardini L, Garnero A, et al. Optimizing Loco Regional Management of Oligometastatic Colorectal Cancer: Technical Aspects and Biomarkers, Two Sides of the Same Coin[J]. Cancers, 2021, 13(11): 2617.
|
| [3] |
中国医师协会外科医师分会, 中华医学会外科分会胃肠外科学组, 中华医学会外科分会结直肠外科学组, 等. 中国结直肠癌肝转移诊断和综合治疗指南(2023版)[J]. 中国普通外科杂志, 2023, 22(1): 1-29.
|
| [4] |
Hasselgren K, Røsok BI, Larsen PN, et al. ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM[J]. Ann Surg, 2021, 273(3): 442-448.
|
| [5] |
Chebaro A, Buc E, Durin T, et al. Liver Venous Deprivation or Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy?[J]. Ann Surg, 2021, 274(5): 874-880.
|
| [6] |
Laurent C, Fernandez B, Marichez A, et al. Radiological Simultaneous Portohepatic Vein Embolization(RASPE) Before Major Hepatectomy[J]. Ann Surg, 2020, 272(2): 199-205.
|
| [7] |
彭淑牖, 黄从云, 李江涛, 等. 末梢门静脉栓塞术在计划性肝切除术中的应用初探[J]. 中华外科杂志, 2016, 54(9): 664-668.
|
| [8] |
彭淑牖, 黄从云, 王许安, 等. 末梢门静脉栓塞技术在余肝体积不足肝细胞癌中的应用价值[J]. 中华外科杂志, 2021, 59(10): 829-835.
|
| [9] |
Walker BS, Billingsley KG, Sutton TL, et al. Hepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases: Outcomes in a newly established program[J]. J Surg Oncol, 2022, 126(3): 513-522.
|
| [10] |
Zhang Y, Wang K, Yang T, et al. Meta-Analysis of Hepatic Arterial Infusion for Liver Metastases From Colorectal Cancer[J]. Front Oncol, 2021, 11: 628558.
|
| [11] |
Datta J, Narayan RR, Kemeny NE, et al. Role of Hepatic Artery Infusion Chemotherapy in Treatment of Initially Unresectable Colorectal Liver Metastases: A Review[J]. JAMA Surg, 2019, 154(8): 768.
|
| [12] |
Koerkamp BG, Sadot E, Kemeny NE, et al. Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis.[J]. J Clin Oncol, 2017(17): 1938-1944.
|
| [13] |
Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update[J]. J Hepatol, 2022, 76(3): 681-693.
|
| [14] |
Gruber Rouh T, Naguib NNN, Eichler K, et al. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: Long-term results over a 10-year period[J]. Int J Cancer, 2014, 134(5): 1225-1231.
|
| [15] |
Vogl TJ, Lahrsow M, Albrecht MH, et al. Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization(cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation[J]. Eur J Radiol, 2018, 102: 138-145.
|
| [16] |
Chen S, Yang Y, Jiao Y, et al. Efficacy of Drug-Eluting Bead Transarterial Chemoembolization in the Treatment of Colorectal Cancer Liver Metastasis[J]. J Healthc Eng, 2022, 2022: 1-5.
|
| [17] |
Fiorentini G, Aliberti C, Tilli M, et al. Intra-arterial infusion of irinotecan-loaded drug-eluting beads(DEBIRI) versus intravenous therapy(FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study[J]. Anticancer Res, 2012, 32(4): 1387-1395.
|
| [18] |
Zhao G, Liu S, Zhang Y, et al. Irinotecan eluting beads-transarterial chemoembolization using Callispheres® microspheres is an effective and safe approach in treating unresectable colorectal cancer liver metastases[J]. Irish J Med Sci, 2022, 191(3): 1139-1145.
|
| [19] |
高洁, 刘晓明, 周文华, 等. 90Y微球的研发现状与应用研究[J]. 同位素, 2022, 35(3): 189-199.
|
| [20] |
Ehrhardt GJ, Day DE. Therapeutic use of 90Y microspheres. Nuel Med Biol, 1987, 3(14): 233-242.
|
| [21] |
Chua TC, Bester L, Saxena A, et al. Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases[J]. J Cancer Res Clin Oncol, 2011, 137(5): 865-873.
|
| [22] |
Entezari P, Gabr A, Salem R, et al. Yttrium-90 for colorectal liver metastasis-the promising role of radiation segmentectomy as an alternative local cure[J]. Int J Hyperthermia, 2022: 39(1): 620-626.
|
| [23] |
Raphael MJ, Karanicolas PJ. Regional Therapy for Colorectal Cancer Liver Metastases: Which Modality and When?[J]. J Clin Oncol, 2022, 40(24): 2806-2817.
|
| [24] |
Ruers T, Van Coevorden F, Punt CJA, et al. Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial[J]. J Natl Cancer Inst, 2017, 109(9): djx015.
|
| [25] |
肖永胜, 郭磊, 叶青海. 结直肠癌肝转移外科治疗[J/OL]. 中华肝脏外科手术学电子杂志, 2019(4): 294-296.
|
| [26] |
Lubner MG, Brace CL, Hinshaw JL, et al. Microwave Tumor Ablation: Mechanism of Action, Clinical Results, and Devices[J]. J Vasc Intervent Radiol, 2010, 21(8): S192-S203.
|
| [27] |
Huang Z, Pan Y, Zhou P, et al. Long-term outcomes of ultrasound-guided percutaneous microwave ablation versus resection for colorectal cancer liver metastases: a propensity-score matched study[J]. Int J Hyperthermia, 2021, 38(1): 1276-1284.
|
| [28] |
Shi Y, Wang Z, Chi J, et al. Long-term results of percutaneous microwave ablation for colorectal liver metastases[J]. HPB, 2021, 23(1): 37-45.
|
| [29] |
Heerink WJ, Solouki AM, Vliegenthart R, et al. The relationship between applied energy and ablation zone volume in patients with hepatocellular carcinoma and colorectal liver metastasis[J]. Eur Radiol, 2018, 28(8): 3228-3236.
|
| [30] |
Mahnken AH, König AM, Figiel JH. Current Technique and Application of Percutaneous Cryotherapy Aktuelle Technik und Anwendung der perkutanen Kryotherapie[J]. Rofo, 2018, 190(9): 836-846.
|
| [31] |
Xu KC, Niu LZ, He WB, et al. Percutaneous cryosurgery for the treatment of hepatic colorectal metastases[J]. World J Gastroenterol, 2008, 14(9): 1430-1436.
|
| [32] |
Pusceddu C, Mascia L, Ninniri C, et al. The Increasing Role of CT-Guided Cryoablation for the Treatment of Liver Cancer: A Single-Center Report[J]. Cancers, 2022, 14(12): 3018.
|
| [33] |
Belfiore MP, De Chiara M, Reginelli A, et al. An overview of the irreversible electroporation for the treatment of liver metastases: When to use it[J]. Front Oncol, 2022, 12: 943176.
|
| [34] |
Koethe Y, Wilson N, Narayanan G. Irreversible electroporation for colorectal cancer liver metastasis: a review[J]. Int J Hyperthermia, 2022, 39(1): 682-687.
|
| [35] |
Zhang X, Zhang X, Ding X, et al. Novel irreversible electroporation ablation(Nano-knife) versus radiofrequency ablation for the treatment of solid liver tumors: a comparative, randomized, multicenter clinical study[J]. Front Oncol, 2022, 12: 945123.
|
| [36] |
Hosein PJ, Echenique A, Loaiza-Bonilla A, et al. Percutaneous Irreversible Electroporation for the Treatment of Colorectal Cancer Liver Metastases with a Proposal for a New Response Evaluation System[J]. J Vasc Interv Radiol, 2014, 25(8): 1233-1239.
|